NAD+ is the most searched longevity supplement category of 2026. NMN, NR, and related precursor compounds have moved from biohacker forums into mainstream consumer awareness, driven in part by research on sirtuins, mitochondrial function, and the NAD+ decline associated with aging.
The mechanism is real and well-documented. NAD+ is a coenzyme present in every cell, central to energy metabolism and DNA repair. Its decline with age is associated with reduced mitochondrial efficiency and impaired cellular maintenance. Supplementing with precursors that support NAD+ production addresses a genuine biological mechanism.
Bioregulator peptides operate in a different but complementary layer of the same longevity biology. Where NAD+ precursors support energy metabolism and DNA repair capacity, bioregulator compounds address gene expression — specifically, the tissue-specific gene programs that age, stress, and accumulated damage have suppressed.
The Khavinson research lineage documents this at the cellular level. Short-chain peptides bind to DNA promoter sequences and activate gene expression that produces functional proteins — collagen in the dermis, barrier components in the epidermis, regulatory peptides in endocrine tissue. The mechanism is not metabolic support. It is gene expression restoration.
For skin specifically, the NAD+ pathway and the bioregulator pathway are additive. Cells with better energy metabolism are more capable of responding to bioregulator signaling. Bioregulator compounds give cells a specific program to execute. NAD+ supports the cellular capacity to execute it.
Epithalon — one of the Khavinson-lineage compounds with the most extensive longevity research — has documented telomerase activation in human somatic cells. In the context of cellular aging, this places it in the same conversation as NAD+ and senolytic research, addressing the upstream biological mechanisms rather than downstream symptoms.
The HelioMend Khavinson Collection addresses the bioregulator layer of this stack. For the visitor building a comprehensive longevity protocol, the compounds in these protocols are designed to complement — not replace — the metabolic support that NAD+ precursors provide.